odronextamab
regeneron
['odronextamab', 'elm-2', 'dlbcl', '$regn']
49% orr with $regn odronextamab in heavily-treated dlbcl, using step-up regimen (elm-2 trial). better than the 40% rate we previously saw in elm-1 #ash22 
News Editor for Vantage covering biopharma and medtech; cat lover; banana run winner